A study published in The Lancet Infectious Diseases found that malaria protection methods for pregnant women in sub-Saharan Africa are underutilized. Despite WHO policy, estimated coverage of intermittent preventive treatment (IPTp) is only 25% and insecticide-treated nets (ITNs) are used by just 17% of pregnant women at risk.
The REBUILD programme will focus on health financing, human resources, and their interaction to strengthen knowledge of rebuilt health systems. It will aim to build knowledge about alternative financial support methods for the public system, including new aid institutions and targeted funding.
The Making It Happen programme, supported by UK's Department for International Development and UNICEF, trains healthcare providers in Africa and Asia to reduce maternal and newborn mortality and morbidity. The programme has already trained over 3000 health care providers, leading to improved clinical practices and reduced deaths.
The Innovative Vector Control Consortium (IVCC) has received a $50 million grant to develop new insecticides for malaria and other neglected tropical diseases. The new funding will support the development of three new Active Ingredients for public health insecticides by 2020.
Researchers at Liverpool School of Tropical Medicine develop a new technique to detect and monitor insecticide resistance in Anopheles funestus mosquitoes. The technique involves forcing female mosquitoes to lay eggs, which are then reared into adult mosquitoes to study levels of resistance to pyrethroid/DDT insecticides.
A €2.75 million programme aims to tackle cultural barriers hindering adolescent reproductive health services in Africa. The initiative will analyse current provision and develop targeted interventions to enhance reach and effectiveness.
A new LSTM-led study aims to investigate the effects of long-term weekly iron and folic acid supplementation on anaemia and malaria risk in young women. The research seeks to strengthen adolescent health services and develop effective preventative programmes for anaemia control.
A new study estimates that over 125 million global pregnancies are at risk from malaria every year, representing 60% of all pregnancies globally. The study provides a reliable estimate of the numbers at risk globally and will inform policy decisions for research and control efforts.
The Liverpool School of Tropical Medicine has received £10m to support programmes reducing LF prevalence and eliminating the disease. Over a billion people are at risk, with 40 million already infected.
IVCC is showcasing its new Malaria Decision Support System (MDSS), a continuous surveillance system that integrates monitoring and evaluation data for malaria control programmes. The system will be demonstrated at the 5th Pan-African Multilateral Initiative on Malaria conference.
The UK International Health Links Centre (IHLC) aims to promote effective international health links between the UK and developing countries. The centre will provide a 'one-stop-shop' for information and guidance on strengthening existing links, as well as a library of resources for international users.
The CRIMALDDI project, led by Liverpool School of Tropical Medicine, aims to coordinate European and international antimalarial drug discovery efforts. The project will develop a prioritized roadmap and 5-year action plan to deliver on this roadmap.
A €1 million grant from the European Commission will support LSTM in developing a national HIV strategy and programme of support for Libya. The project aims to address Libya's priority issues for HIV prevention and care by analyzing data and drawing evidence-based conclusions.
The Liverpool School of Tropical Medicine is launching a £30 million initiative to strengthen health research in Africa. The program will support over 50 institutions across 18 African countries and create postgraduate scholarships for students to research health-related issues.
A £1.1m grant will lead the development of a Field Applicable Screening Tool (FAST) kit to detect insecticide resistance in mosquitoes, crucial for effective malaria control in sub-Saharan Africa. The project aims to identify genes that render mosquitoes resistant to key insecticides.
The European and Developing Countries Clinical Trials Partnership (EDCTP) has awarded €11 million to the MiP Consortium to investigate new approaches to prevent and treat malaria in pregnancy. Researchers aim to develop more effective interventions that can prevent up to 50 million women at risk every year, saving lives and reducing ma...
A £2.8m grant will support a three-year programme to increase skilled birth attendance and quality obstetric care in 5 target countries, aiming to reduce maternal and newborn deaths. The programme will evaluate the impact of training and supportive supervision on healthcare provider capacity and care delivery.
The Liverpool School of Tropical Medicine's Malaria in Pregnancy Consortium has been awarded €3.6 million to research optimizing the use of an antimalarial drug given to prevent malaria in pregnancy in Africa. The project aims to determine whether pregnant women need a different dose of the SP drug due to changes during pregnancy.
Researchers at LSTM and UoL aim to develop a new antimalarial drug that targets a novel enzyme in Plasmodium falciparum, potentially eliminating malaria symptoms. The project will use computational techniques and molecular modeling to design effective inhibitors.
Researchers at Liverpool School of Tropical Medicine have identified two genes associated with resistance to pyrethroid insecticides in Anopheles funestus and Anopheles gambiae mosquitoes. This discovery provides early warning for future control problems due to insecticide resistance.
Liverpool Associates in Tropical Health (LATH) has been awarded a £10 million contract to strengthen Malawi's health research capacity. The initiative aims to enhance institutional capacity for high-quality multi-disciplinary health research and improve the use of research in national policy and implementation.
The RSTMH president calls for a shift in global health priorities to address neglected tropical diseases with effective treatments available at minimal cost. Currently, billions of people lack access to quality healthcare products, hindering their well-being and productivity.
A $30 million grant will fund research to improve malaria control and treatment in pregnancy across Africa, Asia, and Latin America. The initiative aims to reduce maternal anaemia and low birth weight, potentially saving the lives of up to 100,000 children every year.
The Liverpool School of Tropical Medicine has received a $23 million grant to develop new combinations of potential filariasis drugs using state-of-the-art technologies. The programme aims to target bacteria inside the worms, without which they cannot survive, offering a new method to control and treat diseases affecting over 150 milli...